Neurecon BV
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Feasibility of Self-treatment of Painful Diabetic Neuropathy Using Electrical Vasomotor Nerve Stimulation (NCT06524284) | Neurecon BV | 2024-07-22 |
Track Neurecon BV automatically
Every clearance here is in the API, with alerts when new ones post.